Mechanisms and functions of long non‑coding RNAs in glioma (Review)
- Authors:
- Xingjie Chen
- Gaochao Guo
- Yalin Lu
- Shuaishuai Wang
- Yu Zhang
- Qiang Huang
-
Affiliations: Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China, Department of Neurosurgery, Henan Provincial People's Hospital, Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450003, P.R. China - Published online on: February 1, 2021 https://doi.org/10.3892/or.2021.7960
- Article Number: 9
This article is mentioned in:
Abstract
 |
 |
 |
|
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P and Ellison DW: The 2016 world health organization classification of tumors of the central nervous system: A summary. Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Reni M, Mazza E, Zanon S, Gatta G and Vecht CJ: Central nervous system gliomas. Crit Rev Oncol Hematol. 113:213–234. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen R, Smith-Cohn M, Cohen AL and Colman H: Glioma subclassifications and their clinical significance. Neurotherapeutics. 14:284–297. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Alexander BM and Cloughesy TF: Adult glioblastoma. J Clin Oncol. 35:2402–2409. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Taylor OG, Brzozowski JS and Skelding KA: Glioblastoma multiforme: An overview of emerging therapeutic targets. Front Oncol. 9:9632019. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng J, Meng J, Zhu L and Peng Y: Exosomal noncoding RNAs in Glioma: Biological functions and potential clinical applications. Mol Cancer. 19:662020. View Article : Google Scholar : PubMed/NCBI | |
|
Ulitsky I and Bartel DP: lincRNAs: Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lagarde J, Uszczynska-Ratajczak B, Santoyo-Lopez J, Gonzalez JM, Tapanari E, Mudge JM, Steward CA, Wilming L, Tanzer A, Howald C, et al: Extension of human lncRNA transcripts by RACE coupled with long-read high-throughput sequencing (RACE-Seq). Nat Commun. 7:123392016. View Article : Google Scholar : PubMed/NCBI | |
|
Deveson IW, Hardwick SA, Mercer TR and Mattick JS: The dimensions, dynamics, and relevance of the mammalian noncoding transcriptome. Trends Genet. 33:464–478. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Bonasio R and Shiekhattar R: Regulation of transcription by long noncoding RNAs. Annu Rev Genet. 48:433–455. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yan Y, Xu Z, Li Z, Sun L and Gong Z: An insight into the increasing role of lncRNAs in the pathogenesis of gliomas. Front Mol Neurosci. 10:532017. View Article : Google Scholar : PubMed/NCBI | |
|
Engreitz JM, Haines JE, Perez EM, Munson G, Chen J, Kane M, McDonel PE, Guttman M and Lander ES: Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature. 539:452–455. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Quinn JJ and Chang HY: Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 17:47–62. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Huang CK, Kafert-Kasting S and Thum T: Preclinical and clinical development of noncoding RNA therapeutics for cardiovascular disease. Circ Res. 126:663–678. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kato M and Natarajan R: Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat Rev Nephrol. 15:327–345. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Atianand MK, Caffrey DR and Fitzgerald KA: Immunobiology of long noncoding RNAs. Annu Rev Immunol. 35:177–198. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng Z, Li Z, Ma K, Li X, Tian N, Duan J, Xiao X and Wang Y: Long non-coding RNA XIST promotes glioma tumorigenicity and angiogenesis by acting as a molecular sponge of miR-429. J Cancer. 8:4106–4116. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Qian X, Zhao J, Yeung PY, Zhang QC and Kwok CK: Revealing lncRNA structures and interactions by sequencing-based approaches. Trends Biochem Sci. 44:33–52. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Mercer TR and Mattick JS: Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 20:300–307. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Schmitt AM and Chang HY: Long noncoding RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Rinn JL and Chang HY: Genome regulation by long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
St Laurent G, Wahlestedt C and Kapranov P: The Landscape of long noncoding RNA classification. Trends Genet. 31:239–251. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sigova AA, Mullen AC, Molinie B, Gupta S, Orlando DA, Guenther MG, Almada AE, Lin C, Sharp PA, Giallourakis CC and Young RA: Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells. Proc Natl Acad Sci USA. 110:2876–2881. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ørom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q, et al: Long noncoding RNAs with enhancer-like function in human cells. Cell. 143:46–58. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
de Santa F, Barozzi I, Mietton F, Ghisletti S, Polletti S, Tusi BK, Muller H, Ragoussis J, Wei CL and Natoli G: A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol. 8:e10003842010. View Article : Google Scholar : PubMed/NCBI | |
|
Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al: Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ulitsky I, Shkumatava A, Jan CH, Sive H and Bartel DP: Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell. 147:1537–1550. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Fitz J, Neumann T, Steininger M, Wiedemann EM, Garcia AC, Athanasiadis A, Schoeberl UE and Pavri R: Spt5-mediated enhancer transcription directly couples enhancer activation with physical promoter interaction. Nat Genet. 52:505–515. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 25:1915–1927. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Peng Z, Liu C and Wu M: New insights into long noncoding RNAs and their roles in glioma. Mol Cancer. 17:612018. View Article : Google Scholar : PubMed/NCBI | |
|
Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S, Zhang A, Jia Z, Wang G, Yu S, et al: lncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol. 40:2004–2012. 2012.PubMed/NCBI | |
|
Chen G, Cao Y, Zhang L, Ma H, Shen C and Zhao J: Analysis of long non-coding RNA expression profiles identifies novel lncRNA biomarkers in the tumorigenesis and malignant progression of gliomas. Oncotarget. 8:67744–67753. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li Q, Jia H, Li H, Dong C, Wang Y and Zou Z: lncRNA and mRNA expression profiles of glioblastoma multiforme (GBM) reveal the potential roles of lncRNAs in GBM pathogenesis. Tumour Biol. 37:14537–14552. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Xi J, Sun Q, Ma L and Kang J: Long non-coding RNAs in glioma progression. Cancer Lett. 419:203–209. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Malissovas N, Ninou E, Michail A and Politis PK: Targeting long non-coding RNAs in nervous system cancers: New insights in prognosis, diagnosis and therapy. Curr Med Chem. 26:5649–5663. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Q, Cai J, Wang Q, Wang Y, Liu M, Yang J, Zhou J, Kang C, Li M and Jiang C: Long noncoding RNA NEAT1, regulated by the EGFR pathway, contributes to glioblastoma progression through the WNT/β-catenin pathway by scaffolding EZH2. Clin Cancer Res. 24:684–695. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Quagliata L, Matter MS, Piscuoglio S, Arabi L, Ruiz C, Procino A, Kovac M, Moretti F, Makowska Z, Boldanova T, et al: Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology. 59:911–923. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wu P, Cai J, Chen Q, Han B, Meng X, Li Y, Li Z, Wang R, Lin L, Duan C, et al: lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p. Nat Commun. 10:20452019. View Article : Google Scholar : PubMed/NCBI | |
|
Ghafouri-Fard S and Taheri M: Nuclear enriched abundant transcript 1 (NEAT1): A long non-coding RNA with diverse functions in tumorigenesis. Biomed Pharmacother. 111:51–59. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao W, Li W, Jin X, Niu T, Cao Y, Zhou P and Zheng M: Silencing long non-coding RNA NEAT1 enhances the suppression of cell growth, invasion, and apoptosis of bladder cancer cells under cisplatin chemotherapy. Int J Clin Exp Pathol. 12:549–558. 2019.PubMed/NCBI | |
|
Wu Y, Yang L, Zhao J, Li C, Nie J, Liu F, Zhuo C, Zheng Y, Li B, Wang Z and Xu Y: Nuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancer. Mol Cancer. 14:1912015. View Article : Google Scholar : PubMed/NCBI | |
|
Fujimoto A, Furuta M, Totoki Y, Tsunoda T, Kato M, Shiraishi Y, Tanaka H, Taniguchi H, Kawakami Y, Ueno M, et al: Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. Nat Genet. 48:500–509. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang X, Zhou Y, Sun AJ and Xue JL: NEAT1 contributes to breast cancer progression through modulating miR-448 and ZEB1. J Cell Physiol. 233:8558–8566. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Jho EH, Zhang T, Domon C, Joo CK, Freund JN and Costantini F: Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 22:1172–1183. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Tago K, Nakamura T, Nishita M, Hyodo J, Nagai S, Murata Y, Adachi S, Ohwada S, Morishita Y, Shibuya H and Akiyama T: Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. Genes Dev. 14:1741–1749. 2000.PubMed/NCBI | |
|
Pandey GK, Mitra S, Subhash S, Hertwig F, Kanduri M, Mishra K, Fransson S, Ganeshram A, Mondal T, Bandaru S, et al: The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. Cancer Cell. 26:722–737. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang F, Ruan X, Ma J, Liu X, Zheng J, Liu Y, Liu L, Shen S, Shao L, Wang D, et al: DGCR8/ZFAT-AS1 promotes CDX2 transcription in a PRC2 complex-dependent manner to facilitate the malignant biological behavior of glioma cells. Mol Ther. 28:613–630. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
de Klerk E and t Hoen PA: Alternative mRNA transcription, processing, and translation: Insights from RNA sequencing. Trends Genet. 31:128–139. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ong CT and Corces VG: Enhancer function: New insights into the regulation of tissue-specific gene expression. Nat Rev Genet. 12:283–293. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Field A and Adelman K: Evaluating enhancer function and transcription. Annu Rev Biochem. 89:213–234. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, Harmin DA, Laptewicz M, Barbara-Haley K, Kuersten S, et al: Widespread transcription at neuronal activity-regulated enhancers. Nature. 465:182–187. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Mousavi K, Zare H, Dell'orso S, Grontved L, Gutierrez-Cruz G, Derfoul A, Hager GL and Sartorelli V: eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Mol Cell. 51:606–617. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Li W, Notani D, Ma Q, Tanasa B, Nunez E, Chen AY, Merkurjev D, Zhang J, Ohgi K, Song X, et al: Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature. 498:516–520. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ørom UA, Derrien T, Guigo R and Shiekhattar R: Long noncoding RNAs as enhancers of gene expression. Cold Spring Harb Symp Quant Biol. 75:325–331. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Dykes IM and Emanueli C: Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genomics Proteomics Bioinformatics. 15:177–186. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Long Y, Wang X, Youmans DT and Cech TR: How do lncRNAs regulate transcription? Sci Adv. 3:eaao21102017. View Article : Google Scholar : PubMed/NCBI | |
|
Zovoilis A, Cifuentes-Rojas C, Chu HP, Hernandez AJ and Lee JT: Destabilization of B2 RNA by EZH2 activates the stress response. Cell. 167:1788–1802.e13. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Hernandez AJ, Zovoilis A, Cifuentes-Rojas C, Han L, Bujisic B and Lee JT: B2 and ALU retrotransposons are self-cleaving ribozymes whose activity is enhanced by EZH2. Proc Natl Acad Sci USA. 117:415–425. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Espinoza CA, Allen TA, Hieb AR, Kugel JF and Goodrich JA: B2 RNA binds directly to RNA polymerase II to repress transcript synthesis. Nat Struct Mol Biol. 11:822–829. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Lambert SA, Jolma A, Campitelli LF, Das PK, Yin Y, Albu M, Chen X, Taipale J, Hughes TR and Weirauch MT: The human transcription factors. Cell. 172:650–665. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Hudson WH and Ortlund EA: The structure, function and evolution of proteins that bind DNA and RNA. Nat Rev Mol Cell Biol. 15:749–760. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, et al: Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet. 43:621–629. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Xu H, Zhao G, Zhang Y, Jiang H, Wang W, Zhao D, Yu H and Qi L: Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression. J Exp Clin Cancer Res. 38:4862019. View Article : Google Scholar : PubMed/NCBI | |
|
Schneider C, King RM and Philipson L: Genes specifically expressed at growth arrest of mammalian cells. Cell. 54:787–793. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan J, Zhang N, Zheng Y, Chen YD, Liu J and Yang M: lncRNA GAS5 indel genetic polymorphism contributes to glioma risk through interfering binding of transcriptional factor TFAP2A. DNA Cell Biol. 37:750–757. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and Ma W: ceRNA in cancer: Possible functions and clinical implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Amirkhah R, Naderi-Meshkin H, Shah JS, Dunne PD and Schmitz U: The intricate interplay between epigenetic events, alternative splicing and noncoding RNA deregulation in colorectal cancer. Cells. 8:9292019. View Article : Google Scholar | |
|
Zhang XZ, Liu H and Chen SR: Mechanisms of long non-coding RNAs in cancers and their dynamic regulations. Cancers (Basel). 12:12452020. View Article : Google Scholar | |
|
Li Y, Yin Z, Fan J, Zhang S and Yang W: The roles of exosomal miRNAs and lncRNAs in lung diseases. Signal Transduct Target Ther. 4:472019. View Article : Google Scholar : PubMed/NCBI | |
|
Salmena L, Poliseno L, Tay Y, Kats L and Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sa L, Li Y, Zhao L, Liu Y, Wang P, Liu L, Li Z, Ma J, Cai H and Xue Y: The Role of HOTAIR/miR-148b-3p/USF1 on regulating the permeability of BTB. Front Mol Neurosci. 10:1942017. View Article : Google Scholar : PubMed/NCBI | |
|
Qin N, Tong GF, Sun LW and Xu XL: Long noncoding RNA MEG3 suppresses glioma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of miR-19a. Oncol Res. 25:1471–1478. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li DX, Fei XR, Dong YF, Cheng CD, Yang Y, Deng XF, Huang HL, Niu WX, Zhou CX, Xia CY and Niu CS: The long non-coding RNA CRNDE acts as a ceRNA and promotes glioma malignancy by preventing miR-136-5p-mediated downregulation of Bcl-2 and Wnt2. Oncotarget. 8:88163–88178. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D, Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng J, Li XD, Wang P, Liu XB, Xue YX, Hu Y, Li Z, Li ZQ, Wang ZH and Liu YH: CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186. Oncotarget. 6:25339–25355. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng J, Liu X, Wang P, Xue Y, Ma J, Qu C and Liu Y: CRNDE promotes malignant progression of glioma by attenuating miR-384/PIWIL4/STAT3 axis. Mol Ther. 24:1199–1215. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Brockdorff N, Bowness JS and Wei G: Progress toward understanding chromosome silencing by Xist RNA. Genes Dev. 34:733–744. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng Z, Luo C and Guo Z: lncRNA-XIST/microRNA-126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma. J Cell Biochem. 121:2170–2183. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Ule J and Blencowe BJ: Alternative splicing regulatory networks: Functions, mechanisms, and evolution. Mol Cell. 76:329–345. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Shepard PJ and Hertel KJ: The SR protein family. Genome Biol. 10:2422009. View Article : Google Scholar : PubMed/NCBI | |
|
Blencowe BJ: Alternative splicing: New insights from global analyses. Cell. 126:37–47. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Y and Ma L: New insights into long non-coding RNA MALAT1 in cancer and metastasis. Cancers (Basel). 11:2162019. View Article : Google Scholar | |
|
Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Arun G and Spector DL: MALAT1 long non-coding RNA and breast cancer. RNA Biol. 16:860–863. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chang J, Xu W, Du X and Hou J: MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS. Onco Targets Ther. 11:3461–3473. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Le L, Chen H, Gao Y, Wang YW, Zhang GQ, Pan SH, Ji L, Kong R, Wang G, Jia YH, et al: Long noncoding RNA MALAT1 promotes aggressive pancreatic cancer proliferation and metastasis via the stimulation of autophagy. Mol Cancer Ther. 15:2232–2243. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Liao K, Lin Y, Gao W, Xiao Z, Medina R, Dmitriev P, Cui J, Zhuang Z, Zhao X, Qiu Y, et al: Blocking lncRNA MALAT1/miR-199a/ZHX1 axis inhibits glioblastoma proliferation and progression. Mol Ther Nucleic Acids. 18:388–399. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wen F, Cao YX, Luo ZY, Liao P and Lu ZW: lncRNA MALAT1 promotes cell proliferation and imatinib resistance by sponging miR-328 in chronic myelogenous leukemia. Biochem Biophys Res Commun. 507:1–8. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al: The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 39:925–938. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Long JC and Caceres JF: The SR protein family of splicing factors: Master regulators of gene expression. Biochem J. 417:15–27. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Stamm S: Regulation of alternative splicing by reversible protein phosphorylation. J Biol Chem. 283:1223–1227. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Huang B, Song JH, Cheng Y, Abraham JM, Ibrahim S, Sun Z, Ke X and Meltzer SJ: Long non-coding antisense RNA KRT7-AS is activated in gastric cancers and supports cancer cell progression by increasing KRT7 expression. Oncogene. 35:4927–4936. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Yang Z, Trottier J, Barbier O and Wang L: Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay. Hepatology. 65:604–615. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu L, Wei Q, Qi Y, Ruan X, Wu F, Li L, Zhou J, Liu W, Jiang T, Zhang J, et al: PTB-AS, a novel natural antisense transcript, promotes glioma progression by improving PTBP1 mRNA stability with SND1. Mol Ther. 27:1621–1637. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Cao S, Zheng J, Liu X, Liu Y, Ruan X, Ma J, Liu L, Wang D, Yang C, Cai H, et al: FXR1 promotes the malignant biological behavior of glioma cells via stabilizing MIR17HG. J Exp Clin Cancer Res. 38:372019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Wang Y, Li J, Zhang Y, Yin H and Han B: CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Lett. 367:122–128. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Barile L and Vassalli G: Exosomes: Therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 174:63–78. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang L, Gu Y, Du Y and Liu J: Exosomes: Diagnostic biomarkers and therapeutic delivery vehicles for cancer. Mol Pharm. 16:3333–3349. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
D'Asti E, Chennakrishnaiah S, Lee TH and Rak J: Extracellular vesicles in brain tumor progression. Cell Mol Neurobiol. 36:383–407. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Katsuda T, Kosaka N and Ochiya T: The roles of extracellular vesicles in cancer biology: Toward the development of novel cancer biomarkers. Proteomics. 14:412–425. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Vader P, Breakefield XO and Wood MJ: Extracellular vesicles: Emerging targets for cancer therapy. Trends Mol Med. 20:385–393. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Jabbari N, Akbariazar E, Feqhhi M, Rahbarghazi R and Rezaie J: Breast cancer-derived exosomes: Tumor progression and therapeutic agents. J Cell Physiol. 235:6345–6356. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lorenc T, Klimczyk K, Michalczewska I, Słomka M, Kubiak-Tomaszewska G and Olejarz W: Exosomes in prostate cancer diagnosis, prognosis and therapy. Int J Mol Sci. 21:21182020. View Article : Google Scholar | |
|
Sun W, Ren Y, Lu Z and Zhao X: The potential roles of exosomes in pancreatic cancer initiation and metastasis. Mol Cancer. 19:1352020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu L, Li J, Gong Y, Wu Q, Tan S, Sun D, Xu X, Zuo Y, Zhao Y, Wei YQ, et al: Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis. Mol Cancer. 18:742019. View Article : Google Scholar : PubMed/NCBI | |
|
Shah S, Wittmann S, Kilchert C and Vasiljeva L: lncRNA recruits RNAi and the exosome to dynamically regulate pho1 expression in response to phosphate levels in fission yeast. Genes Dev. 28:231–244. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Han M, Gu Y, Lu P, Li J, Cao H, Li X, Qian X, Yu C, Yang Y, Yang X, et al: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation. Mol Cancer. 19:262020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, Yin J, Lu C, Wei Y, Zeng A and You Y: Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma. J Exp Clin Cancer Res. 38:1662019. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan Z, Yang Z, Li W, Wu A, Su Z and Jiang B: Exosome-mediated transfer of long noncoding RNA HOTAIR regulates temozolomide resistance by miR-519a-3p/RRM1 axis in glioblastoma. Cancer Biother Radiopharm. Jul 24–2020.(Epub ahead of print). doi: 10.1089/cbr.2019.3499. View Article : Google Scholar | |
|
Li LJ, Leng RX, Fan YG, Pan HF and Ye DQ: Translation of noncoding RNAs: Focus on lncRNAs, pri-miRNAs, and circRNAs. Exp Cell Res. 361:1–8. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wu P, Mo Y, Peng M, Tang T, Zhong Y, Deng X, Xiong F, Guo C, Wu X, Li Y, et al: Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer. 19:222020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Wu S, Zhu X, Zhang L, Deng J, Li F, Guo B, Zhang S, Wu R, Zhang Z, et al: lncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis. J Exp Med. 217:jem.20190950. 2020. View Article : Google Scholar | |
|
Begum S, Yiu A, Stebbing J and Castellano L: Novel tumour suppressive protein encoded by circular RNA, circ-SHPRH, in glioblastomas. Oncogene. 37:4055–4057. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang M, Huang N, Yang X, Luo J, Yan S, Xiao F, Chen W, Gao X, Zhao K, Zhou H, et al: A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis. Oncogene. 37:1805–1814. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang M, Zhao K, Xu X, Yang Y, Yan S, Wei P, Liu H, Xu J, Xiao F, Zhou H, et al: A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma. Nat Commun. 9:44752018. View Article : Google Scholar : PubMed/NCBI | |
|
Matsui M and Corey DR: Non-coding RNAs as drug targets. Nat Rev Drug Discov. 16:167–179. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Özeş AR, Wang Y, Zong X, Fang F, Pilrose J and Nephew KP: Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer. Sci Rep. 7:8942017. View Article : Google Scholar : PubMed/NCBI | |
|
Bullock MD, Silva AM, Kanlikilicer-Unaldi P, Filant J, Rashed MH, Sood AK, Lopez-Berestein G and Calin GA: Exosomal non-coding RNAs: Diagnostic, prognostic and therapeutic applications in cancer. Noncoding RNA. 1:53–68. 2015.PubMed/NCBI | |
|
H Rashed M, Bayraktar E, K Helal G, Abd-Ellah MF, Amero P, Chavez-Reyes A and Rodriguez-Aguayo C: Exosomes: From garbage bins to promising therapeutic targets. Int J Mol Sci. 18:5382017. View Article : Google Scholar |
